Vaxil Bio Ltd. (TSXV:VXL)
0.1600
0.00 (0.00%)
At close: Aug 18, 2026
Vaxil Bio Balance Sheet
Financials in millions CAD. Fiscal year is January - December.
Millions CAD. Fiscal year is Jan - Dec.
Assets
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Cash & Equivalents | 0.53 | 0.67 | 0.45 | 0.94 | 1.51 | 2.24 |
Cash & Short-Term Investments | 0.53 | 0.67 | 0.45 | 0.94 | 1.51 | 2.24 |
Cash Growth | 30.77% | 49.78% | -52.24% | -37.88% | -32.62% | 48.41% |
Other Receivables | 0.08 | 0 | 0.01 | 0.02 | 0.02 | 0.04 |
Receivables | 0.08 | 0 | 0.27 | 0.02 | 0.02 | 0.04 |
Prepaid Expenses | - | 0.01 | 0.01 | 0.02 | 0.01 | 0.01 |
Total Current Assets | 0.61 | 0.69 | 0.73 | 0.98 | 1.54 | 2.28 |
Property, Plant & Equipment | - | - | - | - | - | 0 |
Long-Term Investments | 0.69 | 0.69 | - | - | - | - |
Total Assets | 1.29 | 1.37 | 0.73 | 0.98 | 1.54 | 2.29 |
Liabilities
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Accounts Payable | 0.03 | 0 | 0.01 | 0.08 | 0.39 | 0.56 |
Accrued Expenses | 0.01 | 0 | 0.01 | 0.01 | 0.01 | 0.03 |
Total Current Liabilities | 0.04 | 0.01 | 0.02 | 0.09 | 0.41 | 0.59 |
Total Liabilities | 0.04 | 0.01 | 0.02 | 0.09 | 0.41 | 0.59 |
Shareholders' Equity
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Common Stock | 16.13 | 16.13 | 16.07 | 16.07 | 16.07 | 16.07 |
Retained Earnings | -19.12 | -19.01 | -19.54 | -19.36 | -19.1 | -18.52 |
Comprehensive Income & Other | 4.25 | 4.25 | 4.18 | 4.17 | 4.17 | 4.14 |
Shareholders' Equity | 1.26 | 1.37 | 0.72 | 0.89 | 1.14 | 1.7 |
Total Liabilities & Equity | 1.29 | 1.37 | 0.73 | 0.98 | 1.54 | 2.29 |
Additional Metrics
Fiscal Year | TTM | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 |
|---|---|---|---|---|---|---|
Period Ending | Mar '26 Mar 31, 2026 | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 |
Net Cash (Debt) | 0.53 | 0.67 | 0.45 | 0.94 | 1.51 | 2.24 |
Net Cash Growth | 30.77% | 49.78% | -52.24% | -37.88% | -32.62% | 49.30% |
Net Cash Per Share | 0.17 | 0.24 | 0.16 | 0.34 | 0.55 | 0.82 |
Filing Date Shares Outstanding | 3.98 | 3.98 | 2.74 | 2.74 | 2.74 | 2.74 |
Total Common Shares Outstanding | 3.98 | 3.98 | 2.74 | 2.74 | 2.74 | 2.74 |
Working Capital | 0.57 | 0.68 | 0.72 | 0.89 | 1.14 | 1.7 |
Book Value Per Share | 0.32 | 0.34 | 0.26 | 0.33 | 0.41 | 0.62 |
Tangible Book Value | 1.26 | 1.37 | 0.72 | 0.89 | 1.14 | 1.7 |
Tangible Book Value Per Share | 0.32 | 0.34 | 0.26 | 0.33 | 0.41 | 0.62 |
Machinery | - | - | - | - | - | 0.21 |